This is the first study assessing the clinical management of severe, isolated dysphonia
during post-COVID-19 syndrome. One hundred and fifty-eight subjects met the inclusion …

Introduction Dysphonia has been described in patients affected by coronavirus disease
2019 (COVID-19). The aim of this study was to evaluate the prevalence of dysphonia, and its …

COVID-19 is considered a respiratory disease which has many symptoms associated with
the larynx and the lungs infections. COVID-19 has wide spectrum of clinical features starting …

Introduction The main objective of this study is to estimate the prevalence of persistent
dysphonia in hospitalised COVID-19 patients. Methods Data were collected from those …

Introduction To explore the prevalence of dysphonia in European patients with mild-to-
moderate COVID-19 and the clinical features of dysphonic patients. Methods The clinical …

Introduction: Due to the upper and lower respiratory involvement in coronavirus disease
2019 (COVID-19), the voice quality of these patients is expected to be impaired. In this study …

It's been almost a year since the World Health Organization declared the novel Coronavirus
outbreak as a global pandemic in March 2020. Amid the continuous effort to curb the …

Background Dysphonia and laryngeal pathology are considerable issues in patients
hospitalised with COVID-19 with prevalence rates cited between 29% and 79%. Most …

Background Dysphonia is a feature of the COVID-19 disease with different prevalence rates
of occurrence among various nations. Objectives To determine the prevalence of dysphonia …

We read the article entitled:“Prevalence of dysphonia due to COVID-19 at Salahaddin
General Hospital, Tikrit City, Iraq”[1]. Authors investigated the prevalence of dysphonia in …